MEGACHOLIN RF 500MG TABLET contains Citicoline which belongs to a group of medicines called Psychostimulants. MEGACHOLIN RF 500MG TABLET is used to treat cerebral insufficiency (such as dizziness, memory loss, poor circulation, disorientation) that occurs due to head trauma/brain injury in affected individuals.
MEGACHOLIN RF 500MG TABLET is also used to treat cognitive dysfunction that occurs due to Alzheimer’s disease (brain disease that affects memory and thinking skills) and other cerebrovascular disease. It is also indicated for use in acute and recovery phase of cerebral infarction (condition that occurs due to poor blood supply to the brain) and Parkinson’s disease (age related degenerative brain condition) in affected individuals.
MEGACHOLIN RF 500MG TABLET is not recommended for use in patients allergic to Citicoline. It is also not recommended for use in patients suffering from hypertonia (muscle overactivity).
Before taking MEGACHOLIN RF 500MG TABLET, inform your doctor if you are scheduled for any surgery, and/or have persistent intracranial haemorrhage, kidney/liver disease.
MEGACHOLIN RF 500MG TABLET should be used with caution in pregnant and breastfeeding women only if necessary. It is also advised to be used with caution in children and adolescents (aged below 18 years) if necessary. The medicine is also advised to be used with caution in elderly patients (aged above 65 years) after consulting the doctor.
The most common side effects of taking MEGACHOLIN RF 500MG TABLET are nausea, vomiting, constipation, headache, low blood pressure, and/or agitation. Consult your doctor if any of these symptoms worsens.
MEGACHOLIN RF 500MG TABLET works by increasing the synthesis of phosphatidylcholine (chemical that produces acetylcholine, responsible for memory and other bodily functions) which leads to improved cerebral function and cognitive function in Alzheimer’s disease and Parkinson’s disease. It also works by repairing neuronal membranes and damaged cholinergic neurons via potentiation of acetylcholine production and reduction of free fatty acid accumulation at stroke-induced nerve damage site which results in the prevention neuronal cell death thus helping in the recovery phase of cerebral infarction in affected individuals.
Tablet:
Take MEGACHOLIN RF 500MG TABLET as advised by your physician. Swallow the medicines with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
Orally Disintegrating Tablet:
Take MEGACHOLIN RF 500MG TABLET as advised by your physician. Place MEGACHOLIN RF 500MG TABLET inside your mouth and allow it to dissolve completely. Do not swallow or chew the medicine. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
Nausea and vomiting:
Take MEGACHOLIN RF 500MG TABLET with or just after a meal. Stick to simple meals. Avoid eating oil rich or spicy foods, sugary snacks and drinks. Avoid drinking too much liquid along with your meals, drink slowly in between meals. Inform your doctor if the condition worsens.
Constipation:
Try to eat high-fiber foods such as vegetables, cereals, fresh fruit, and drink plenty of water. Involve in regular exercise (going for a daily walk or run) and if this does not help, consult and inform your doctor for receiving alternate treatments for constipation.
Headache:
If MEGACHOLIN RF 500MG TABLET causes headache, then take rest and drink plenty of fluids. Try to avoid drinking alcohol. Ask your doctor to recommend a painkiller. Headaches should usually go away after the first week of taking MEGACHOLIN RF 500MG TABLET. If it lasts more than a week or severe, inform your doctor.
MEGACHOLIN RF 500MG TABLET should be used with caution during pregnancy only if it is clearly necessary. Consult your doctor before taking MEGACHOLIN RF 500MG TABLET.
MEGACHOLIN RF 500MG TABLET should be used with caution in breastfeeding women only if it is clearly necessary. Consult your doctor before taking MEGACHOLIN RF 500MG TABLET.
Do not drive/operate machines while taking MEGACHOLIN RF 500MG TABLET since it may affect your ability to drive/operate machines.
MEGACHOLIN RF 500MG TABLET should be used with caution in patients with kidney disease. Consult your doctor before taking MEGACHOLIN RF 500MG TABLET.
MEGACHOLIN RF 500MG TABLET should be used with caution in patients with liver disease. Consult your doctor before taking MEGACHOLIN RF 500MG TABLET.
Do not take MEGACHOLIN RF 500MG TABLET if you are allergic to Citicoline, and/or any other ingredients of this medicine.
MEGACHOLIN RF 500MG TABLET is not recommended for use if you have:
Before taking MEGACHOLIN RF 500MG TABLET, inform your doctor if you:
MEGACHOLIN RF 500MG TABLET should be used with caution in children and adolescents (aged below 18 years) only if it is clearly necessary. Consult your doctor before taking MEGACHOLIN RF 500MG TABLET.
Use in Geriatrics:
MEGACHOLIN RF 500MG TABLET should be used with caution in elderly patients (aged above 65 years). Consult your doctor before taking the medicine.
A. Drug - Drug interactions:
Before taking MEGACHOLIN RF 500MG TABLET, inform your doctor if you are taking any of the following medicine:
Overdosage:
If you or anyone else accidentally take too much of MEGACHOLIN RF 500MG TABLET, consult your doctor immediately or visit the nearby hospital.
Drug | : | Citicoline |
Pharmacological Category | : | Pyrimidine ribonucleoside diphosphates |
Therapeutic Indication | : | Cerebral insufficiency, Cognitive dysfunction (due to Alzheimer’s disease), Parkinson’s disease |
Dosage Forms | : | Tablet, Injection, Syrup, Solution, Oral drops |
What is MEGACHOLIN RF 500MG TABLET is used for?
MEGACHOLIN RF 500MG TABLET is used to treat cerebral insufficiency that occurs due to head trauma/brain injury in affected individuals. It is also used to treat cognitive dysfunction that occurs due to Alzheimer’s disease (brain disease that affects memory and thinking skills) and other cerebrovascular disease. It is also indicated for use in acute and recovery phase of cerebral infarction (condition that occurs due to poor blood supply to the brain) and Parkinson’s disease (age related degenerative brain condition) in affected individuals.
What are the side effects of MEGACHOLIN RF 500MG TABLET?
The most common side effects of taking MEGACHOLIN RF 500MG TABLET are nausea, vomiting, constipation, headache, low blood pressure, and/or agitation. Consult your doctor if any of these symptoms worsens.
How MEGACHOLIN RF 500MG TABLET works?
MEGACHOLIN RF 500MG TABLET works by increasing the synthesis of phosphatidylcholine (chemical that produces acetylcholine, responsible for memory and other bodily functions) which leads to improved cerebral function and cognitive function in Alzheimer’s disease and Parkinson’s disease. It also works by repairing neuronal membranes and damaged cholinergic neurons via potentiation of acetylcholine production and reduction of free fatty acid accumulation at stroke-induced nerve damage site which results in the prevention neuronal cell death thus helping in the recovery phase of cerebral infarction in affected individuals.
What happens if more than required dosage of MEGACHOLIN RF 500MG TABLET is taken?
If you or anyone else accidentally take too much of MEGACHOLIN RF 500MG TABLET, consult your doctor immediately or visit the nearby hospital to manage the overdose symptoms.
Can MEGACHOLIN RF 500MG TABLET be used in pregnant and breastfeeding women?
Yes, MEGACHOLIN RF 500MG TABLET can be used but with caution in pregnant and breastfeeding women only if it is clearly necessary. Consult your doctor before taking MEGACHOLIN RF 500MG TABLET.
1. KD. Tripathi. CNS Stimulants and Cognition Enhancers. Essentials of medical pharmacology. Seventh edition. 2013. Page - 491.
2. Cochrane Stroke Group, Arturo J Martí-Carvajal, Claudia Valli, Cristina Elena Martí-Amarista, Ivan Solà, Joan Martí-Fàbregas, Xavier Bonfill Cosp. Citicoline for treating people with acute ischemic stroke. NIH National Library of Medicine. National Center for Biotechnology Information. PMC PubMed Central. [Revised in August 2020] [Accessed on 6th May 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406786/
3. Antonino Maria Cotroneo, Alberto Castagna, Salvatore Putignano, Roberto Lacava, Fausto Fantò, Francesco Monteleone,5 Filomena Rocca, Alba Malara, Pietro Gareri. Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study. NIH National Library of Medicine. National Center for Biotechnology Information. PMC PubMed Central. [Revised in February 2013] [Accessed on 6th May 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569046/
4. UniLab, Inc. Citicoline. [Revised in June 2015] [Accessed on 6th May 2022] https://www.unilab.com.ph/products/cholinerv
5. Vidhyasha Pharmaceuticals. Citipro 250. [Accessed on 6th May 2022] http://vidhyasha.in/tablets-capsules-approved-list/#
6. Actiza Pharmaceutical Private Limited. Citicoline Tablets. [Accessed on 6th May 2022] https://www.actizapharma.com/products/citicoline/
7. Alpha Drugs. COLCIT -500. [Accessed on 6th May 2022] https://www.alphadrug.in/product/colcit-500/
8. StayHappi Pharmacy. Citicoline Tablets IP. [Accessed on 6th May 2022] https://www.stayhappi.com/stayhappi-generics/citicoline-500-mg-tablet-10s-8708
9. Cipla Ltd. COGNOLIN 500 Tablets. [Accessed on 6th May 2022] https://www.ciplamed.com/content/cognolin-500-tablets
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.